Adverum Biotechnologies (ADVM)
(Real Time Quote from BATS)
$7.98 USD
+0.20 (2.57%)
Updated Jul 11, 2024 12:26 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -1.27 |
EPS Last Quarter | -1.50 |
Last EPS Surprise | -17.19% |
ABR | 1.25 |
Earnings ESP
|
1.38% |
---|---|
Current Year | -5.07 |
Next Year | -5.18 |
EPS (TTM) | -10.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.53M | 0.56M | 1.67M | 1.59M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.53M | 0.56M | 1.67M | 1.59M |
Low Estimate | 0.53M | 0.56M | 1.67M | 1.59M |
Year ago Sales | 0.00M | 0.00M | 3.60M | 1.67M |
Year over Year Growth Est. | NA | NA | -53.61% | -4.79% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.27 | -1.17 | -5.07 | -5.18 |
# of Estimates | 4 | 3 | 6 | 5 |
Most Recent Consensus | -1.31 | NA | -5.54 | NA |
High Estimate | -1.22 | -0.95 | -4.50 | -3.99 |
Low Estimate | -1.31 | -1.31 | -5.54 | -5.79 |
Year ago EPS | -3.10 | -3.30 | -11.60 | -5.07 |
Year over Year Growth Est. | 59.03% | 64.55% | 56.29% | -2.27% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.27 | -1.17 | -5.07 | -5.18 |
7 Days Ago | -1.27 | -1.17 | -5.07 | -5.18 |
30 Days Ago | -1.27 | -1.28 | -5.42 | -5.55 |
60 Days Ago | -1.26 | -1.26 | -5.25 | -5.54 |
90 Days Ago | -1.20 | -1.20 | -5.18 | -5.47 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.25 | -0.95 | -4.65 | -4.31 |
Zacks Consensus Estimate | -1.27 | -1.17 | -5.07 | -5.18 |
Earnings ESP | 1.38% | 18.57% | 8.29% | 16.89% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.50 | -2.30 | -3.30 | -3.10 | NA |
Estimate | -1.28 | -2.80 | -3.00 | -3.20 | NA |
Difference | -0.22 | 0.50 | -0.30 | 0.10 | 0.02 |
Surprise | -17.19% | 17.86% | -10.00% | 3.12% | -1.55% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more